Syntimmune Company
Syntimmune develops differentiated drug candidates in a wide range of autoimmune diseases.
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2013
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership